Chemoinformaics analysis of 5-methoxy-6,7-methylenedioxyflavone
| Molecular Weight | 296.278 | nRot | 2 |
| Heavy Atom Molecular Weight | 284.182 | nRig | 22 |
| Exact Molecular Weight | 296.068 | nRing | 4 |
| Solubility: LogS | -4.927 | nHRing | 2 |
| Solubility: LogP | 3.669 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 40.4015 |
| nHD | 0 | BPOL | 19.8505 |
| QED | 0.727 |
| Synth | 2.351 |
| Natural Product Likeliness | 1.19 |
| NR-PPAR-gamma | 0.236 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.638 |
| MDCK | 0.0000211 |
| BBB | 0.04 |
| PPB | 0.926211 |
| VDSS | 0.624 |
| FU | 0.0502437 |
| CYP1A2-inh | 0.978 |
| CYP1A2-sub | 0.569 |
| CYP2c19-inh | 0.961 |
| CYP2c19-sub | 0.129 |
| CYP2c9-inh | 0.853 |
| CYP2c9-sub | 0.919 |
| CYP2d6-inh | 0.843 |
| CYP2d6-sub | 0.867 |
| CYP3a4-inh | 0.903 |
| CYP3a4-sub | 0.169 |
| CL | 6.992 |
| T12 | 0.201 |
| hERG | 0.127 |
| Ames | 0.67 |
| ROA | 0.063 |
| SkinSen | 0.55 |
| Carcinogencity | 0.897 |
| EI | 0.659 |
| Respiratory | 0.426 |
| NR-Aromatase | 0.701 |
| Antiviral | Yes |
| Prediction | 0.789674 |